Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
custo med is a German healthcare technology company focused on cardiopulmonary diagnostics and cardiological rehabilitation for hospitals, clinics, and private practices. The company develops and commercializes integrated diagnostic software, medical devices, and workflow solutions spanning resting and stress ECG, Holter ECG, ambulatory blood pressure monitoring, and spirometry. Its core platform, custo diagnostic, is a modular software environment designed to unify cardiopulmonary testing and support clinical workflows, including hospital IT integration. The company also highlights deep-learning-enabled long-term ECG analysis and clinically validated phenotype analysis for hypertension-related cardiovascular assessment. Overall, custo med appears to be a commercial-stage medtech diagnostics company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on custo med.